Dave Gardner
Patrimonio netto: 912 161 $ in data 31/05/2026
Patrimonio netto: 912 161 $ in data 31/05/2026
Dave Gardner is Chief Strategy Officer & Executive Vice President at Incyte Corp.
since 2025.
Former roles include Director at Xilio Therapeutics, Inc., Vice President at BlackRock Finance, Inc. from 2006 to 2015, and Analyst at Rock Springs Capital Management LP from 2015 to 2025.
Education includes an MBA from Columbia Business School conferred in 2015 and an undergraduate degree from McIntire School of Commerce.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/09/2025 | 9.429 ( 0% ) | 912 161 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 22/09/2025 |
| Società | Posizione | Fine |
|---|---|---|
Rock Springs Capital Management LP
Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing. | Analyst-Equity | 01/09/2025 |
BlackRock Finance, Inc.
BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Corporate Officer/Principal | 01/05/2015 |
| XILIO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
BlackRock Finance, Inc.
BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Finance |
Rock Springs Capital Management LP
Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing. | Finance |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McIntire School of Commerce
McIntire School of Commerce Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale